Nyhet -

Bengt Hedin talar om cGMP-tillverkning den 29 Augusti i Köpenhamn

Den 29 Augusti pratar Bengt Hedin, senior CMC konsult på SDS Life Science om vägen till cGMP tillverkning på eventet ''Optimizing Oral Bioavailability and Translating Formulation Advances for Clinical Success'' i Köpenhamn.

Evenemanget organiseras i ett samarbete mellan Medicon Valley Alliance och Catalent Pharma Solutions.

Titeln på Bengts föredrag är ''Planning the Development Path into cGMP Manufacturing''.

Om evenemanget

''Oral solid dosage forms remain a preferred option for many pharmaceutical drug developers. However, their successful development and manufacture still present several unique challenges and opportunities. This event brings together pharmaceutical experts to discuss such challenges and offer solutions for improving bioavailability, applying different pharmaceutical technologies for dosage form designs, optimizing manufacturing, and accelerating progression to the clinic and on to market success. Experts will offer insights into enabling formulation technologies including lipid based formulation and solid dispersion, and share approaches to transitioning from preclinical toxicology to a viable formulation in the clinics in an accelerated pathway.''

Registrering

https://www.catalent.com/event...

Ämnen

  • Hälsa, sjukvård, läkemedel

Regioner

  • Stockholm

Kontakter

Adam Svender

Presskontakt Marknadskoordinator Marknad & kommunikation 0760060855

Relaterat innehåll